IPO registrations (S-1, F-1) · Registrants

ACHILLION PHARMACEUTICALS INC

SEC CIK
1070336 · filings on EDGAR ↗
Registration
Form S-1, first filed 2006-03-31, last 2009-08-14; 2 initial registrations, 8 amendments
Outcome
Final prospectus filed 2006-10-26; declared effective 2006-10-25; withdrawal requested 2006-10-18
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
300 GEORGE STREET, New Haven, CT 06511
EDGAR entity type
operating
Insiders and CEO pay
ACHILLION PHARMACEUTICALS INC on the corporate pages

Offering terms

Proposed price range
$14.00–$16.00 per share (S-1/A filed 2006-10-25)
Final price
$11.50 per share, below the range (424B4 filed 2006-10-26, an initial public offering)
Shares sold
4,500,000
Gross proceeds
$51,750,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ACHN
Lead underwriters
Cowen; CIBC World Markets; JMP Securities

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 20

FiledFormWhat it isName as filedEDGAR
2006-03-31S-1S-1 (registration)ACHILLION PHARMACEUTICALS INC0001193125-06-070902 ↗
2006-05-17S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-114379 ↗
2006-06-06S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-124479 ↗
2006-09-01S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-183778 ↗
2006-09-22S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-194948 ↗
2006-10-02S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-200497 ↗
2006-10-10S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-204889 ↗
2006-10-18RWRW (withdrawal request)ACHILLION PHARMACEUTICALS INC0001193125-06-210019 ↗
2006-10-20S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-211314 ↗
2006-10-25S-1/AS-1/A (amendment)ACHILLION PHARMACEUTICALS INC0001193125-06-214521 ↗
2006-10-25EFFECTEFFECT (declared effective)ACHILLION PHARMACEUTICALS INC9999999995-06-002034 ↗
2006-10-26424B4424B4 (final prospectus)ACHILLION PHARMACEUTICALS INC0001193125-06-215579 ↗
2008-04-11RWRW (withdrawal request)ACHILLION PHARMACEUTICALS INC0001193125-08-079933 ↗
2008-10-30EFFECTEFFECT (declared effective)ACHILLION PHARMACEUTICALS INC9999999995-08-003245 ↗
2009-08-14S-1S-1 (registration)ACHILLION PHARMACEUTICALS INC0001193125-09-176126 ↗
2009-09-21EFFECTEFFECT (declared effective)ACHILLION PHARMACEUTICALS INC9999999995-09-002616 ↗
2009-10-16EFFECTEFFECT (declared effective)ACHILLION PHARMACEUTICALS INC9999999995-09-002882 ↗
2010-05-26EFFECTEFFECT (declared effective)ACHILLION PHARMACEUTICALS INC9999999995-10-001619 ↗
2010-09-30EFFECTEFFECT (declared effective)ACHILLION PHARMACEUTICALS INC9999999995-10-002837 ↗
2011-04-25EFFECTEFFECT (declared effective)ACHILLION PHARMACEUTICALS INC9999999995-11-001154 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2006-10-25S-1/Aregistration statement$14.00–$16.004,500,000-Nasdaq ACHN3primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3document ↗
2006-10-26424B4final prospectus$11.504,500,000$51,750,000Nasdaq ACHN3primary document; price sentence, shares headline, proceeds table, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ADVENT HEALTHCARE & LIFE SCIENCES II KGOther22006
ADVENT HEALTHCARE & LIFE SCIENCES II LPOther22006
ADVENT INTERNATIONAL CORP/MAOther22006
ADVENT INTERNATIONAL LIMITED PARTNERSHIPOther22006
ADVENT PARTNERS HLS II LIMITED PARTNERSHIPOther22006
ADVENT PARTNERS LIMITED PARTNERSHIPOther22006
ATLAS VENTURE ASSOCIATES V LPTenPercentOwner22006
ATLAS VENTURE ENTREPRENEURS FUND V LPTenPercentOwner22006
ATLAS VENTURE FUND V LPTenPercentOwner22006
ATLAS VENTURE PARALLEL FUND V-A C VTenPercentOwner22006
Deshpande MilindDirector,Officer; OfficerChief Executive Officer; EVP and CSO; President and CEO; President and CSO; President of R&D and CSO; Pres R&D and CSO; SVP and Chief Scientific Ofc.; SVP and CSO242006–2018
Fenton Mary KayOfficerChief Financial Officer; EVP and CFO; SVP and CFO; Vice President and CFO232006–2018
FISHERMAN JASON SDirector292006–2020
FORMELA JEAN FRANCOISDirector,TenPercentOwner32006–2007
GARVEY JAMES MDirector,TenPercentOwner32006–2007person page Fuzzy
GILEAD SCIENCES INCTenPercentOwner22006
GREY MICHAEL GDirector62006–2009
KISHBAUCH MICHAEL DDirector; Director,OfficerCEO and President222006–2020
Pottage John C JrOfficerSVP and Chief Medical Officer22006
RYSER STEFANDirector22006
Scheer DavidDirector192006–2020
SCHRODER VENTURE MANAGERS LTDTenPercentOwner22006
SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1TenPercentOwner22006
Schroder Ventures International Life Sciences Fund II L.P.2TenPercentOwner22006
Schroder Ventures International Life Sciences Fund II L.P.3TenPercentOwner22006
Schroder Ventures International Life Sciences Fund II Strategic Partners L.P.TenPercentOwner22006
SCHRODER VENTURES MANAGERS INCTenPercentOwner22006
Shah GautamOfficerEVP and Chief Compliance Ofc.; SVP and Chief Compliance Ofc.292006–2014
SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment SchemeTenPercentOwner22006
SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTDTenPercentOwner22006
WHITE CHRISTOPHER ADirector22006
VAN NOSTRAND ROBERT LDirector182007–2020
WRIGHT DAVID PDirector122007–2012
Olek Elizabeth AOfficerSenior Vice President and CMO; SVP and CMO; Vice President and CMO92007–2012
FRASHIER GARY EDirector192008–2018
Clarus Lifesciences II, L.P.TenPercentOwner102008–2012
Clarus Ventures II GP, L.P.TenPercentOwner102008–2012
Clarus Ventures II, LLCTenPercentOwner102008–2012
GALAKATOS NICHOLASTenPercentOwner102008–2012
HENNER DENNISTenPercentOwner102008–2012
Leiden JeffreyTenPercentOwner82008–2010
LIPTAK ROBERTTenPercentOwner102008–2012
Simon NicholasDirector; Director,TenPercentOwner; TenPercentOwner152008–2012
STEINMETZ MICHAELTenPercentOwner102008–2012
WHEELER KURTTenPercentOwner102008–2012
Moorin JayTenPercentOwner22008–2009
ProQuest Associates IV LLCTenPercentOwner22008–2009
ProQuest Investments IV, L.P.TenPercentOwner22008–2009
SCHREIBER ALAINTenPercentOwner22008–2009
INVESTOR ABTenPercentOwner82008–2010
INVESTOR GROWTH CAPITAL LTDTenPercentOwner62008–2010
Liotta DennisDirector152008–2014
Truitt JosephDirector,Officer; OfficerChief Commercial Officer; Chief Executive Officer; EVP, Chief Commercial Officer; SVP, Chief Commercial Officer; VP, Chief Commercial Officer202009–2020
BLAIR JAMES CTenPercentOwner42010–2013
Domain Partners VIII, L.P.TenPercentOwner32010–2013
DOVEY BRIAN HTenPercentOwner42010–2013
DP VIII Associates, L.P.TenPercentOwner12010
Halak Brian KTenPercentOwner42010–2013
SCHOEMAKER KATHLEEN KTenPercentOwner42010–2013
TREU JESSE ITenPercentOwner42010–2013
VITULLO NICOLEDirector; Director,TenPercentOwner; TenPercentOwner222010–2020
Quaker BioVentures II LPTenPercentOwner42010–2011
DOMAIN ASSOCIATESTenPercentOwner12010
Kamdar Kim P.TenPercentOwner12012
Graves KurtDirector102012–2020
QVT Associates GP LLCTenPercentOwner142013–2014
Apelian DavidOfficerChief Medical Officer; EVP and Chief Medical Officer; EVP and CMO82013–2017
QVT Fund V LPTenPercentOwner62013
Kolchinsky PeterOther; TenPercentOwner; TenPercentOwnerOther192013–2015
RA Capital Healthcare Fund LPOther; TenPercentOwner; TenPercentOwnerOther192013–2015
RA CAPITAL MANAGEMENT, LLCOther; TenPercentOwner; TenPercentOwnerOther212013–2015
JOHNSON & JOHNSONTenPercentOwner22015–2017
Johnson & Johnson Innovation - JJDC, Inc.TenPercentOwner22015–2017
Verwiel FrankDirector72015–2020
Barrish Joel COfficerChief Scientific Officer52016–2017
MANNING MARTHA EOfficerEVP, General Counsel; General Counsel72016–2020
Gibney Anthony SOfficerChief Business Officer; EVP, Chief Business Officer42018–2020
Zelenkofske StevenOfficerChief Medical Officer; EVP, Chief Medical Officer42018–2020
Firuta Paul EOfficerChief Operating Officer; EVP, Chief Commercial Officer42018–2020
Lantz KeriOfficerSee Remarks22019
Di Donato BrianOfficerChief Financial Officer; SVP, Chief Financial Officer42019–2020
G1 EXECUTION SERVICES, LLCTenPercentOwner22020
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLCTenPercentOwner22020
SUSQUEHANNA SECURITIES, LLCTenPercentOwner22020

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationACHILLION PHARMACEUTICALS, INC.CTState business registriesname and state
Plan sponsorACHILLION PHARMACEUTICALS, INC.CTForm 5500 (employee benefit plans)name and state
Federal award recipientACHILLION PHARMACEUTICALS, INC.CTFederal spending (USAspending)name and state
Patent assigneeAchillion Pharmaceuticals, Inc.CTPatents (USPTO)name and state
SEC filerACHILLION PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerAchillion Pharmaceuticals, Inc.CTTrademarks (USPTO)name and state
Person pageJames M GarveyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CT first:

More with this interest.

In other datasets, the same topic (Health) in CT:

Interests: Pharmaceutical Preparations · Health